dimarts, 23 de setembre del 2014

Medtronic, Covidien slide on new U.S. inversion rules




New rules on inversion mergers announced yesterday by the U.S. Treasury Dept. send shares of Medtronic and Covidien down as questions swirl about the impact ion their pending $43 billion merger.








read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1ogcNZ4

Cap comentari:

Publica un comentari a l'entrada